Cofoe at MEDICA 2025: More Than Just Innovation—integrated Solutions for A Healthier World

Cofoe at MEDICA 2025: More than just innovation—integrated solutions for a healthier world

From November 17-20, 2025, the world's largest and most influential medical industry event—the International Medical Device Equipment Exhibition in Düsseldorf, Germany (MEDICA 2025)—was grandly held. Coinciding with the company's 20th anniversary, Cofoe made a splendid appearance with full range of innovative products and smart health solutions, leveraging two decades of deep expertise focused on home healthcare to demonstrate the technical capabilities and brand appeal of "Innovated in China" to the global market.

At MEDICA, Cofoe showcased a lineup of industry-first innovations. The highlights featured an all-in-one monitor and its test strips boasting the unique "One-Strip, Dual-Test" technology for simultaneous blood glucose and uric acid measurement; a projection-guided thermometer, honored with the MUSE Design Award; and an intelligent non-invasive ventilator, innovatively engineered without sound-absorbing cotton.

Subsidiary Shanghai Huazhou displayed its latest series of products such as foam dressings, hydrocolloid dressings, and medical tapes. Meanwhile, Jerry Medical presented its newest carbon fiber electric wheelchair series alongside classic manual and electric wheelchair lines. This rich product matrix covers multiple scenarios including home monitoring, chronic disease management, and rehabilitation care, comprehensively showcasing the innovative strength and industrial advancement of China's home medical device sector.

Two Decades, One Ecosystem: Built on Integrated Strength

Since company establishment in 2005, cofoe has deeply cultivated the home medical device field for twenty years, having built a complete, integrated industrial chain encompassing R&D, production, sales, and service. Our products span five major domains: Health Monitoring, Rehabilitation Aids, and Respiratory Support, among others, exceeding 200 categories and tens of thousands of product specifications, serving over 50 million families globally.

According to a Frost & Sullivan report, in 2024, Cofoe ranked second in sales among Chinese home medical device enterprises, and firmly held the top position in the Rehabilitation Aids sector. In the third quarter of 2025, company achieved an operating revenue of 902 million RMB, a year-on-year increase of 30.72%; net profit attributable to shareholders was 92.8298 million RMB, a year-on-year increase of 38.68%, with both revenue and profit reaching record highs for the same period.

Strategic Evolution: From Channel Strength to R&D Drive, Fueling Results

In its early stages, company established a nationwide sales network through offline pharmacy channels. With the rapid development of internet healthcare, the company proactively obtained B2C qualifications, promoted the integrated development of online and offline businesses, and achieved breakthroughs in building own brand, successfully realizing the strategic transformation from being "channel-driven" to "innovation-driven."

Currently, Cofoe has established three major research institutes, with an R&D team of nearly 400 people, building a market demand-oriented R&D mechanism. Company has accumulated nearly 700 authorized patents and launches over a hundred new products annually. The continuously emerging innovative achievements consistently consolidate its competitive advantage in the home health management field.

Going Global. Aiming Higher.

Internationalization is the core direction of Cofoe Medical's medium to long-term strategy. In the first half of this year, our overseas business revenue increased by over 200% year-on-year, and products have entered more than 60 countries and regions worldwide, with the pace of internationalization continuously accelerating.

Company completed the acquisitions of Shanghai Huazhou and Hong Kong Humana this year, further perfecting overseas channel network, and submitted a listing application to the Hong Kong Stock Exchange to further expand the global market.

Over the past twenty years, Cofoe Medical has progressed from Hunan to the whole nation, and then from China to the world, continuously enhancing the accessibility of healthcare through innovative products and inclusive services.

Looking forward, company will continue to prioritize R&D innovation as the core driving force, launching more products and solutions that meet the health needs of global families. Cofoe aims to serve global users with higher quality and higher standard products, steadfastly advancing towards the goal of becoming a "world-class medical device enterprise."